Commerce de gros (commerce interentreprises) de produits pharmaceutiquesNAF 46.46Z
Commerce de gros (commerce interentreprises) de produits pharmaceutiques : sector financial statistics
The sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z)
comprises 2 065 active companies in France,
of which 2 065 publish their accounts.
The median sector revenue is 9.1 M€
with a median net income of 144 k€
(data from 2025).
Frequently asked questions about the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
How many companies operate in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques ?
The sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z) has 2 065 active companies in France (source INSEE SIRENE), of which 2 065 publish their annual accounts (source INPI). The statistics presented here are based on companies that publish their accounts.
What is the median revenue of the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques ?
The median revenue of companies in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques is 9.1 M€ (data from 2025). This means that half of the companies in the sector have lower revenue, and the other half have higher revenue.
What are the largest companies in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques ?
The main companies in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques by revenue are : OCP REPARTITION (6.8 Mds€), COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE (5.0 Mds€), ALLIANCE HEALTHCARE REPARTITION (4.1 Mds€), MSD FRANCE (2.7 Mds€), CONFRATERNELLE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE RHIN RHONE MEDITERRANEE (2.6 Mds€). See the table above for the complete ranking.
How is the sector doing Commerce de gros (commerce interentreprises) de produits pharmaceutiques ?
The sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques shows a median net income positive of 144 k€, which indicates overall healthy profitability.